• Latest Posts

Ipsen acquired OctreoPharm to strengthen its Oncology presence

Boehringer kindles NASH treatments with Pharmaxis’ drug acquisition

European companies present their cancer treatment solutions in the USA

European Union supports Bavarian Nordic to cure Ebola

Eli Lilly signs a €250M deal with BioNTech for new Cancer Immunotherapies

US-based Juno Therapeutics purchased a German biotech

ADVERTISEMENT

MorphoSys acquired Lanthio, a Dutch Peptide Therapeutic company

Omeicos is moving forward with the appointment of D. Ulrich Dauer

Flagship Ventures recruited a Dream Team composed of Astra Zeneca, Bayer and Nestlé

Isis Pharmaceuticals and Bayer HealthCare team up to prevent thrombosis

Natural Killer therapies for Cancer: a Fast-Evolving field

Sygnis on the way to conquer the UK Life Sciences market

ADVERTISEMENT